Brugada SyndromeSymptoms, Doctors, Treatments, Advances & More
Brugada Syndrome Overview
Learn About Brugada Syndrome
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Office
Dan Roden is a Cardiologist practicing medicine in Nashville, Tennessee. Dr. Roden is rated as an Elite provider by MediFind in the treatment of Brugada Syndrome. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Long QT Syndrome 5, Long QT Syndrome, Jervell Lange-Nielsen Syndrome (JLNS), Cardiac Ablation, and Percutaneous Coronary Intervention (PCI).
Connie Bezzina practices practicing medicine in Amsterdam, Netherlands. Ms. Bezzina is rated as an Elite expert by MediFind in the treatment of Brugada Syndrome. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Brugada Syndrome, Long QT Syndrome, Ventricular Fibrillation, and Cardiomyopathy.
Wataru Shimizu practices practicing medicine in Sendagi, Japan. Mr. Shimizu is rated as an Elite expert by MediFind in the treatment of Brugada Syndrome. He is also highly rated in 49 other conditions, according to our data. His clinical expertise encompasses Ventricular Fibrillation, Long QT Syndrome, Brugada Syndrome, Cardiac Ablation, and Percutaneous Coronary Intervention (PCI).
Summary: Each year world-wide, 2.5 million fetuses die unexpectedly in the last half of pregnancy, 25,000 in the United States, making fetal demise ten-times more common than Sudden Infant Death Syndrome. This study will apply a novel type of non-invasive monitoring, called fetal magnetocardiography (fMCG) used thus far to successfully evaluate fetal arrhythmias, in order to discover potential hidden elect...
Summary: The goal of this observational study is to develop a registry of Brazilian patients with hereditary cardiovascular diseases, combining clinical and genomic data. The main questions it aims to answer are: Which genes are most commonly affected? What is the frequency of these genetic alterations in our population? Participants will be interviewed in routine medical care visits and their DNA will be ...


